Endocrinology · Primary Ovarian Insufficiency

Long-Term Health, Survivorship, and Monitoring

At a Glance

Women with Primary Ovarian Insufficiency (POI) face increased risks for osteoporosis, heart disease, and cognitive issues due to early estrogen loss. Taking Hormone Replacement Therapy (HRT) until age 50 and following a lifelong monitoring plan significantly reduces these risks.

Living with Primary Ovarian Insufficiency (POI) means your body is experiencing a prolonged lack of estrogen during years when it would normally be at its highest. This is more than a reproductive issue; it is a systemic condition that requires proactive, lifelong monitoring of your bones, heart, and mind ^[1]^[2]. The good news is that starting and maintaining Hormone Replacement Therapy (HRT) until age 50 significantly reduces many of these risks ^[3]^[4].

Protecting Your Skeleton

Estrogen is essential for building and maintaining strong bones. Without it, the body breaks down bone faster than it can replace it.

Osteoporosis Risk: Women with POI face a higher risk of osteopenia (low bone mass) and osteoporosis (weak, brittle bones), which can lead to fractures much earlier in life than expected ^[5]^[6].
The DEXA Scan: A DEXA scan (Dual-Energy X-ray Absorptiometry) is the standard tool used to measure your bone mineral density (BMD) ^[7]. You should have a baseline scan at diagnosis, with follow-ups every 3 to 5 years depending on your initial results ^[7]^[8].

Cardiovascular and Metabolic Health

Estrogen helps keep blood vessels flexible and maintains healthy cholesterol levels. The loss of estrogen in POI can lead to an “older” cardiovascular profile in a younger body.

Heart Disease and Stroke: POI is associated with an increased risk of coronary artery disease and cardiovascular mortality ^[9]^[10]. This is partly due to changes in your lipid profile (cholesterol and triglycerides) ^[11].
The Power of HRT: Timely initiation of HRT has been shown to effectively eliminate the increased risk of cardiovascular death associated with POI by protecting the health of your arteries ^[3]^[12].

Cognitive and Mental Health

The impact of POI on the brain is profound, affecting both your long-term cognitive health and your daily emotional well-being.

Brain Fog and Cognition: Many women report “brain fog” or difficulty with memory and concentration. While research is ongoing regarding the long-term risk of dementia, maintaining estrogen levels through HRT is thought to support cognitive function ^[13].
Emotional Well-being: POI is linked to higher rates of depression, anxiety, and psychological distress ^[14]^[15]. The diagnosis can feel like a profound loss, and it is normal to experience a period of grief. Specialized psychological support is often a critical part of a POI care plan ^[16]^[17].

Your Survivorship Checklist

Proactive monitoring is your best defense. Use this table to guide discussions with your care team:

Focus Area	Tool/Test	Frequency
Bone Health	DEXA Scan	Baseline; then every 3–5 years ^[7]
Heart Health	Blood Pressure	Every 12 months ^[11]
Metabolic	Lipid Panel	Every 12 months ^[11]
Nutrition	Vitamin D / Calcium	Check levels annually ^[4]
Emotional	Mental Health Screen	At every appointment ^[14]

Lifestyle as Medicine

While HRT is the foundation of treatment, your daily habits play a major role in your long-term health:

Weight-Bearing Exercise: Activities like walking, jogging, or weightlifting stimulate bone cells to stay active ^[4].
Nutrition: Aim for 1000–1200mg of calcium daily through diet or supplements, and ensure adequate Vitamin D (800–1000 IU) intake ^[4].
Smoking Cessation: Smoking is highly toxic to the ovaries and significantly accelerates bone loss and heart disease ^[10]. Stopping smoking is one of the most impactful things you can do for your health ^[4].

Common questions in this guide

How often do I need a DEXA scan if I have POI?

You should have a baseline DEXA scan when you are first diagnosed with Primary Ovarian Insufficiency to check your bone density. After that, follow-up scans are typically recommended every three to five years, depending on your initial results.

Does premature menopause increase my risk for heart disease?

Yes, the loss of estrogen associated with premature menopause can lead to an increased risk of heart disease and negative changes in your cholesterol levels. However, starting and maintaining Hormone Replacement Therapy (HRT) until age 50 significantly protects your arteries and reduces these cardiovascular risks.

How does POI affect my memory and mental health?

Many women with POI experience brain fog, difficulty concentrating, anxiety, or depression due to the sudden drop in estrogen. Taking Hormone Replacement Therapy can help support your cognitive function, and specialized psychological support is highly recommended to help with emotional well-being.

What lifestyle changes can protect my health with POI?

Quitting smoking is the most important step, as smoking accelerates bone loss and heart disease. Additionally, taking 1000 to 1200mg of calcium daily, ensuring adequate Vitamin D intake, and engaging in regular weight-bearing exercises like walking or lifting weights will help protect your long-term health.

Curated prompts to bring to your next appointment.

1.What was the exact result of my baseline DEXA scan, and when should we schedule the next one?
2.Are my blood pressure and cholesterol levels within the healthy range for a woman of my age?
3.If I am feeling significantly anxious or depressed, can you refer me to a therapist who understands the emotional impact of POI?
4.How often should we be checking my Vitamin D and calcium levels to ensure my bone protection is optimized?
5.Are there specific types of weight-bearing exercise that you recommend for me based on my current bone health?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (17)

1
Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge.
Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al.
International journal of molecular sciences 2021; (22(5)) doi:10.3390/ijms22052594.
PMID: 33807517
2
Is Early Menopause a Different Entity From Premature Ovarian Insufficiency?
Anagnostis P, Lambrinoudaki I, Goulis DG
Clinical endocrinology 2025; (102(1)):67-74 doi:10.1111/cen.15136.
PMID: 39279431
3
Premature and Early Menopause in Relation to Cardiovascular Disease.
Schipper I, Louwers YV
Seminars in reproductive medicine 2020; (38(4-05)):270-276 doi:10.1055/s-0040-1722318.
PMID: 33511582
4
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
Sullivan SD, Sarrel PM, Nelson LM
Fertility and sterility 2016; (106(7)):1588-1599 doi:10.1016/j.fertnstert.2016.09.046.
PMID: 27912889
5
Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.
Jones AR, Enticott J, Ebeling PR, et al.
Human reproduction (Oxford, England) 2024; (39(5)):1013-1022 doi:10.1093/humrep/deae037.
PMID: 38396142
6
Bone mineral density in patients with primary ovarian insufficiency: A systematic review and Meta-Analysis.
Jiang M, Gao Y, Hou H, et al.
European journal of obstetrics, gynecology, and reproductive biology 2024; (295()):219-227 doi:10.1016/j.ejogrb.2024.02.013.
PMID: 38387304
7
Impact of Hormonal Replacement Therapy on Bone Mineral Density in Premature Ovarian Insufficiency Patients.
Podfigurna A, Maciejewska-Jeske M, Nadolna M, et al.
Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9123961.
PMID: 33297406
8
Osteoporosis: Current Concepts.
Akkawi I, Zmerly H
Joints 2018; (6(2)):122-127 doi:10.1055/s-0038-1660790.
PMID: 30051110
9
Coronary artery calcification in middle-aged women with premature ovarian insufficiency.
Gunning MN, Meun C, van Rijn BB, et al.
Clinical endocrinology 2019; (91(2)):314-322 doi:10.1111/cen.14003.
PMID: 31049984
10
Body composition in women with premature ovarian insufficiency using hormone therapy and the relation to cardiovascular risk markers: A case-control study.
Freitas ATA, Donovan Giraldo AE, Pravatta Rezende G, et al.
Clinical endocrinology 2021; (94(1)):111-118 doi:10.1111/cen.14331.
PMID: 32939768
11
Lipid Profile in Patients With Primary Ovarian Insufficiency: A Systematic Review and Meta-Analysis.
Huang L, Wang H, Shi M, et al.
Frontiers in endocrinology 2022; (13()):876775 doi:10.3389/fendo.2022.876775.
PMID: 35757391
12
Metabolic Changes in Patients with Premature Ovarian Insufficiency: Adipose Tissue Focus-A Narrative Review.
Sánchez-García M, León-Wu K, de Miguel-Ibáñez R, et al.
Metabolites 2025; (15(4)) doi:10.3390/metabo15040242.
PMID: 40278371
13
Premature Ovarian Insufficiency.
Kapoor E
Current opinion in endocrine and metabolic research 2023; (28()) doi:10.1016/j.coemr.2023.100435.
PMID: 36936056
14
The risk of depressive and anxiety symptoms in women with premature ovarian insufficiency: a systematic review and meta-analysis.
Xi D, Chen B, Tao H, et al.
Archives of women's mental health 2023; (26(1)):1-10 doi:10.1007/s00737-022-01289-7.
PMID: 36705738
15
Relationship between menopausal status and suicidal behavior among the Korean population.
Son J, Lee W
Maturitas 2025; (195()):108221 doi:10.1016/j.maturitas.2025.108221.
PMID: 39985948
16
Mood disorders in women with premature ovarian insufficiency.
Słopień R
Przeglad menopauzalny = Menopause review 2018; (17(3)):124-126 doi:10.5114/pm.2018.78556.
PMID: 30356982
17
Sexuality in premature ovarian insufficiency.
Nappi RE, Cucinella L, Martini E, et al.
Climacteric : the journal of the International Menopause Society 2019; (22(3)):289-295 doi:10.1080/13697137.2019.1575356.
PMID: 30900474

This page provides educational information about long-term health and monitoring for Primary Ovarian Insufficiency. It does not replace professional medical advice from your endocrinologist or gynecologist.

Get notified when new evidence is published on premature menopause.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents